Canopy Growth sees positive earnings ahead thanks to cost savings

Medical Oil Cannabis - marijuana oil, resin and flowers with Canada flag on the mirror black background.

Kazyaka/iStock via Getty Images

Reporting its Q2 results for fiscal 2025 on Friday, Canadian cannabis operator Canopy Growth (NASDAQ:CGC) projected positive adjusted EBITDA at the company level in the coming quarters as its cost-saving measures offset declining revenue.

The Smiths Falls, Canada-based firm reported C$63.0M

Leave a Reply

Your email address will not be published. Required fields are marked *